Patent details

Basic Information

Publication number:

EP1641465

PCT Application Number:

PCT/US/2004/014168

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP048093611

PCT Publication Number:

WO/2005/025555

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMBINATIONS OF AN ARYL ANILINE BETA-2 ADRENERGIC RECEPTOR AGONIST AND A CORTICOSTEROID

French Title of Invention:

COMBINAISONS D'UN AGONISTE ARYLANILINE DU RECEPTEUR BETA-2 ADRENERGIQUE ET UN CORTICOÏDE

German Title of Invention:

KOMBINATIONEN AUS EINEM ARYLANILIN-BETA-2-ADRENOZEPTOR-AGONISTEN UND EINEM CORTICOSTEROID

SPC Number:

Dates

Filing date:

07/05/2004

Grant date:

04/11/2009

EP Publication Date:

04/11/2009

PCT Publication Date:

24/03/2005

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

05/04/2006

EP B1 Publication Date:

04/11/2009

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

07/05/2010

Expiration date:

07/05/2024

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

07/05/2004

 

 

Name:

Theravance Inc.

Address:

901 Gateway Boulevard, South San Francisco, CA 94080, United States (US)

Inventor

1

Name:

AGGEN James, B.

Address:

United States (US)

2

Name:

NODWELL Matthew, B.

Address:

Canada (CA)

3

Name:

TRAPP Sean, G.

Address:

United States (US)

4

Name:

LEADBETTER Michael, R.

Address:

United States (US)

5

Name:

CHURCH Timothy, J.

Address:

United States (US)

6

Name:

MORAN Edmund, J.

Address:

United States (US)

7

Name:

JACOBSEN John, R.

Address:

United States (US)

Priority

Priority Number:

431762

Priority Date:

08/05/2003

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/58;

Filing date	Document type	Number of pages